ColleenAnnTimlinPharmD

PubMed

• 8 citations
  Evidence for and Against Green Tea and Turmeric in the Management of Chronic Lymphocytic Leukemia
  Erin Bange, Colleen Timlin, Charlene C. Kabel, Jakub Svoboda, Lindsey E. Roeker, Anthony R. Mato> ;Clinical Lymphoma, Myeloma & Leukemia. 2018 Oct 1
• Tocilizumab for the Treatment of Severe Steroid-Refractory Acute Graft-Versus-Host Disease of the Lower Gastrointestinal Tract
  Saar I Gill, Noelle V Frey, Selina M Luger, Edward A Stadtmauer, James K Mangan, Daria V Babushok, Jacqueline Smith, Colleen Timlin, David L Porter, Craig W Freyer, El...> ;Nature.
• 292 citations
  Toxicities and outcomes of 616 ibrutinib-treated patients in the United States: a real-world analysis
  Anthony R. Mato, Chadhi Nabhan, Meghan C. Thompson, Nicole Lamanna, Danielle M. Brander, Brian T. Hill, Christina Howlett, Alan P Skarbnik, Bruce D. Cheson, Clive S. Z...> ;Haematologica. 2018 May 1
• Optimal Sequencing of Ibrutinib, Idelalisib, and Venetoclax in Chronic Lymphocytic Leukemia: Results from a Multicenter Study of 683 Patients
  J Svoboda, C S Ujjani, C Timlin, S J Schuster, N Lamanna, B D Cheson, C Daniel> ;Annals of Oncology. 2017 Apr 30
• Optimal Sequencing of Ibrutinib, Idelalisib, and Venetoclax in Chronic Lymphocytic Leukemia: Results from a Multi-Center Study of 683 Patients.
  Mato, A. R.,Hill, B. T.,Lamanna, N.,Barr, P. M.,Ujjani, C. S.,Brander, D. M.,Howlett, C.,Skarbnik, A. P.,Cheson, B. D.,Zent, C. S.,Pu, J. J.,Kiselev, P.,Foon, K.,Lenha...> ;Ann. Oncol.. 2017 Jan 29
• Join now to see all